ROCKWELL MEDICAL, INC. Finance Lease, Right-of-Use Asset, Amortization
ROCKWELL MEDICAL, INC. (RMTI) reported Finance Lease, Right-of-Use Asset, Amortization of $101.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $101.00K, a 27.34% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $102.00K, a 26.62% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $101.00K, a 26.81% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $109.00K, a 21.58% decline year-over-year.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $488.00K, a 12.70% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $559.00K, a 1.06% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $565.00K, a 0.00% change from fiscal 2022.
- ROCKWELL MEDICAL, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $565.00K, a 80.51% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $101.00K 10-Q · filed 2026-08-13 | $203.00K 10-Q · filed 2026-08-13 | $304.00K derived: sum of 3 quarters · filed 2026-08-13 | $413.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $102.00K 10-Q · filed 2026-05-07 | $203.00K derived: sum of 2 quarters · filed 2026-05-07 | $312.00K derived: sum of 3 quarters · filed 2026-05-07 | $451.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $210.00K derived: sum of 2 quarters · filed 2026-03-26 | $349.00K derived: sum of 3 quarters · filed 2026-08-13 | $488.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $109.00K 10-Q · filed 2025-11-12 | $248.00K derived: sum of 2 quarters · filed 2026-08-13 | $387.00K 10-Q · filed 2025-11-12 | $525.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $139.00K 10-Q · filed 2026-08-13 | $278.00K 10-Q · filed 2026-08-13 | $416.00K derived: sum of 3 quarters · filed 2026-08-13 | $555.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $139.00K 10-Q · filed 2026-05-07 | $277.00K derived: sum of 2 quarters · filed 2026-05-07 | $416.00K derived: sum of 3 quarters · filed 2026-05-07 | $557.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $277.00K derived: sum of 2 quarters · filed 2026-03-26 | $418.00K derived: sum of 3 quarters · filed 2026-03-26 | $559.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $139.00K 10-Q · filed 2025-11-12 | $280.00K derived: sum of 2 quarters · filed 2025-11-12 | $421.00K 10-Q · filed 2025-11-12 | $562.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $141.00K 10-Q · filed 2025-08-14 | $282.00K 10-Q · filed 2025-08-14 | $423.00K derived: sum of 3 quarters · filed 2025-08-14 | $565.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $141.00K 10-Q · filed 2025-05-12 | $282.00K derived: sum of 2 quarters · filed 2025-05-12 | $424.00K derived: sum of 3 quarters · filed 2025-05-12 | $565.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $283.00K derived: sum of 2 quarters · filed 2025-03-20 | $424.00K derived: sum of 3 quarters · filed 2025-03-20 | $565.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $142.00K 10-Q · filed 2024-11-12 | $283.00K derived: sum of 2 quarters · filed 2024-11-12 | $424.00K 10-Q · filed 2024-11-12 | $565.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $141.00K 10-Q · filed 2024-08-08 | $282.00K 10-Q · filed 2024-08-08 | $423.00K derived: sum of 3 quarters · filed 2024-08-08 | $564.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $141.00K 10-Q · filed 2024-05-14 | $282.00K derived: sum of 2 quarters · filed 2024-05-14 | $423.00K derived: sum of 3 quarters · filed 2024-05-14 | $564.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $282.00K derived: sum of 2 quarters · filed 2024-03-21 | $423.00K derived: sum of 3 quarters · filed 2024-03-21 | $565.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $141.00K 10-Q · filed 2023-11-14 | $282.00K derived: sum of 2 quarters · filed 2023-11-14 | $424.00K 10-Q · filed 2023-11-14 | $552.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $141.00K 10-Q · filed 2023-08-14 | $282.00K 10-Q · filed 2023-08-14 | $411.00K derived: sum of 3 quarters · filed 2023-08-14 | $484.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $141.00K 10-Q · filed 2023-05-15 | $270.00K derived: sum of 2 quarters · filed 2023-05-15 | $343.00K derived: sum of 3 quarters · filed 2023-05-15 | $410.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $202.00K derived: sum of 2 quarters · filed 2023-03-30 | $269.00K derived: sum of 3 quarters · filed 2023-03-30 | $313.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $73.00K 10-Q · filed 2022-11-14 | $140.00K derived: sum of 2 quarters · filed 2022-11-14 | $184.00K 10-Q · filed 2022-11-14 | $203.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $67.00K 10-Q · filed 2022-08-15 | $112.00K 10-Q · filed 2022-08-15 | $130.00K derived: sum of 3 quarters · filed 2022-08-15 | $130.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $45.00K 10-Q · filed 2022-05-16 | $63.00K derived: sum of 2 quarters · filed 2022-05-16 | $63.00K derived: sum of 3 quarters · filed 2022-05-16 | $63.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $18.00K derived: sum of 2 quarters · filed 2022-04-08 | $18.00K derived: sum of 3 quarters · filed 2022-04-08 | $18.00K 10-K · filed 2022-04-08 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |